Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04797468
Status:
WITHDRAWN
Last Update Posted:
2023-01-17
First Post:
2021-03-04
Brief Title:
A Phase 1 Study of the CD73 InhibitorHLX23 Alone in Participants With Solid Tumor
Sponsor:
Shanghai Henlius Biotech
Organization:
Shanghai Henlius Biotech
Organization Data
Organization:
Shanghai Henlius Biotech
Class:
INDUSTRY
Study ID:
HLX23-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Henlius Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None